Form 4 for CL Colgate-Palmolive
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0001225208-24-008720 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | 2024-09-12 | CL | Wallace Noel R. | COB, Pres, CEO, Dir | A - Grant | $0.00 | +20.7K | 307.8K | +7% | $0 |
| D | 2024-09-16 | 2024-09-13 | CL | Wallace Noel R. | COB, Pres, CEO, Dir | F - Tax | $105.73 | -4,039 | 303.8K | -1% | -$427.0K |
| D | 2024-09-16 | 2024-09-12 | CL | Wallace Noel R. | COB, Pres, CEO, Dir | A - Grant | $0.00 | +145.7K | 145.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | A | A | 20,689 | $0.00 | 307,848 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-13 | F | D | 4,039 | $105.73 | 303,809 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-09-12 | A | A | 145,696 | $0.00 | 145,696 | D | $106.34 · — to 2032-09-12 | 145,696 Common Stock | (F4) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 12, 2024 grant date. |